Colandrea; Vincent J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Colandrea; Vincent J..The latest application filed is for "c-mannoside compounds useful for the treatment of urinary tract infections".

Company Profile

3.16.15

Colandrea; Vincent J. - King of Prussia PA
Colandrea; Vincent J. - Collegeville PA
Colandrea; Vincent J. - North Brunswick NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bisaryl amides as NRF2 activators Grant 11,078,216 - Callahan , et al. August 3, 2	2021-08-03
C-mannoside Compounds Useful For The Treatment Of Urinary Tract Infections App 20210017212 - BISHOP; Michael Joseph ; et al.	2021-01-21
Bisaryl Amides As Nrf2 Activators App 20190330238 - CALLAHAN; James Francis ; et al.	2019-10-31
Cyclic amine substituted heterocyclic CETP inhibitors Grant 9,353,101 - Acton, III , et al. May 31, 2	2016-05-31
Substituted benzopiperazines as CETP inhibitors Grant 9,126,976 - Anand , et al. September 8, 2	2015-09-08
Cyclic Amine Substituted Heterocyclic Cetp Inhibitors App 20150111866 - Acton, III; John J. ; et al.	2015-04-23
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment Grant 8,957,062 - Edmondson , et al. February 17, 2	2015-02-17
Benzopiperazine Derivatives As Cetp Inhibitors App 20140357632 - Anand; Rajan ; et al.	2014-12-04
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents Grant 8,796,258 - Anand , et al. August 5, 2	2014-08-05
Substituted Cycloproply Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20140057893 - Edmondson; Scott ; et al.	2014-02-27
Tetrahydrofuropyridones Grant 8,471,024 - Colandrea , et al. June 25, 2	2013-06-25
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents App 20130123237 - Anand; Rajan ; et al.	2013-05-16
Tetrahydro-1H-pyrrolo fused pyridones Grant 8,372,863 - Clements , et al. February 12, 2	2013-02-12
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,354,403 - Edmondson , et al. January 15, 2	2013-01-15
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120157432 - Edmondson; Scott D. ; et al.	2012-06-21
Substituted Esters as Cannabinoid-1 Receptor Modulators App 20120135975 - Colandrea; Vincent J. ; et al.	2012-05-31
Tetrahydro-1h-pyrrolo Fused Pyridones App 20110009406 - Clements; Matthew J. ; et al.	2011-01-13
Tetrahydrofuropyridones App 20100331358 - Colandrea; Vincent J. ; et al.	2010-12-30
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists Grant 7,605,171 - Colandrea , et al. October 20, 2	2009-10-20
(3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists App 20080249093 - Colandrea; Vincent J. ; et al.	2008-10-09
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,157,490 - Colandrea , et al. January 2, 2	2007-01-02
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists App 20060252741 - Colandrea; Vincent J. ; et al.	2006-11-09
Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20050222140 - Colandrea, Vincent J. ; et al.	2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.